Leveraging Real World Evidence for drug approval
Alongside presenting exciting opportunities, Real World Evidence still meets some skepticism around the data versus randomized clinical trials, and a number of challenges still need to be overcome.
We spoke to experienced RWE ambassador, Dan Danielson, Senior Director of the Access Experience Team at Precision for Value to explore the benefits, opportunities and challenges that RWE presents drug manufacturers.